THE IMPACT OF THERAPY ON ANTI-CARBAMYLATED PROTEIN ANTIBODY ISOTYPES AND SEROSTATUS IN PATIENTS WITH EARLY RA TREATED WITH ABATACEPT AND METHOTREXATE